Axsome Therapeutics
(NASDAQ) AXSM
Axsome Therapeutics Financials at a Glance
Market Cap
$12.75B
Revenue (TTM)
$708.24M
Net Income (TTM)
-$188.30M
EPS (TTM)
-$3.74
P/E Ratio
-66.28
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$247.96
Volume
32,051
Open
$249.23
Price
$247.96
Volume
32,051
Open
$249.23
Previous Close
$247.96
Daily Range
$246.63 - $252.60
52-Week Range
$96.09 - $260.19
Estimated Earnings Date
Aug 3, 2026
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$247.96
Volume
32,051
Open
$249.23
Previous Close
$247.96
Daily Range
$246.63 - $252.60
52-Week Range
$96.09 - $260.19
Estimated Earnings Date
Aug 3, 2026
AXSM News
Best Biotech ETFs to Buy in 2026
AXSM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Axsome Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
1,220
CEO
Herriott Tabuteau, MD
Website
www.axsome.comHeadquarters
New York City, NY 10007, US
AXSM Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-25%
Net Income Margin
-27%
Return on Equity
-349%
Return on Capital
-64%
Return on Assets
-26%
Earnings Yield
-1.51%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.75B
Shares Outstanding
51.46M
Volume
32.05K
Avg. Volume
728.84K
Financials (TTM)
Gross Profit
$591.02M
Operating Income
-$169.24M
EBITDA
-$168.08M
Operating Cash Flow
-$93.41M
Capital Expenditure
-$480.00K
Free Cash Flow
-$93.89M
Cash & ST Invst.
$322.93M
Total Debt
$241.30M
Axsome Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$191.20M
+57.4%
Gross Profit
$176.48M
+58.0%
Gross Margin
92.30%
N/A
Market Cap
$12.75B
N/A
Market Cap/Employee
$17.91M
N/A
Employees
712
N/A
Net Income
-$64.54M
-8.6%
EBITDA
-$61.08M
-11.4%
Quarterly Fundamentals
Total Cash
$305.11M
+1.4%
Total Debt
$219.90M
+4.1%
Accounts Receivable
$251.06M
+55.6%
Inventory
$31.52M
+93.1%
Long Term Debt
$146.08M
-30.1%
Short Term Debt
$73.82M
+3152.0%
Return on Assets
-26.39%
N/A
Return on Invested Capital
-64.00%
N/A
Free Cash Flow
-$20.82M
+52.4%
Operating Cash Flow
-$20.70M
+52.3%